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Abstract
There is a need for a regional assessment of the frequency and diversity of MRSA to determine major circulating clones and
the extent to which community and healthcare MRSA reservoirs have mixed. We conducted a prospective cohort study of
inpatients in Orange County, California, systematically collecting clinical MRSA isolates from 30 hospitals, to assess MRSA
diversity and distribution. All isolates were characterized by spa typing, with selective PFGE and MLST to relate spa types
with major MRSA clones. We collected 2,246 MRSA isolates from hospital inpatients. This translated to 91/10,000 inpatients
with MRSA and an Orange County population estimate of MRSA inpatient clinical cultures of 86/100,000 people. spa type
genetic diversity was heterogeneous between hospitals, and relatively high overall (72%). USA300 (t008/ST8), USA100 (t002/
ST5) and a previously reported USA100 variant (t242/ST5) were the dominant clones across all Orange County hospitals,
representing 83% of isolates. Fifteen hospitals isolated more t008 (USA300) isolates than t002/242 (USA100) isolates, and 12
hospitals isolated more t242 isolates than t002 isolates. The majority of isolates were imported into hospitals. Community-
based infection control strategies may still be helpful in stemming the influx of traditionally community-associated strains,
particularly USA300, into the healthcare setting.
Citation: Hudson LO, Murphy CR, Spratt BG, Enright MC, Elkins K, et al. (2013) Diversity of Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Isolated from
Inpatients of 30 Hospitals in Orange County, California. PLoS ONE 8(4): e62117. doi:10.1371/journal.pone.0062117
Editor: Herminia de Lencastre, Rockefeller University, United States of America
Received November 25, 2012; Accepted March 18, 2013; Published April 2 , 2013
Copyright:  2013 Hudson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the University of California Irvine, Biotechnology and Biological Sciences Research Council [grant number BB/D52637X/1]
and The Wellcome Trust [grant number 089472/Z/09/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: b.spratt@imperial.ac.uk
¤ Current address: AmpliPhi Biosciences, Sharnbrook, Bedfordshire, United Kingdom
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a major
global cause of morbidity and mortality, imposing serious
economic costs on patients and hospitals [1–3]. Prior to the mid-
1990s, MRSA was largely a healthcare-associated pathogen,
causing infection predominantly in people with frequent or recent
contact with healthcare facilities (healthcare-associated MRSA
[HA-MRSA]). In the US, MRSA carriage (both asymptomatic
and symptomatic) is estimated at 6–12% in general hospital
patient populations and 9–24% in intensive care units (ICUs) [4–
6]. HA-MRSA has long been the primary cause of MRSA
infections, but community-associated MRSA (CA-MRSA), which
often causes infections among healthy children and young adults
with no exposure to the healthcare setting, has become in-
creasingly prevalent across the globe, particularly in the US [7–
10]. While well documented in the community, there is increasing
evidence that CA-MRSA has become established in many
healthcare MRSA settings [11–14]. CA-MRSA has caused
outbreaks in the hospital setting since 2003, often in pediatrics
and obstetrics where HA-MRSA prevalence is low and commu-
nity influx of patients without prior healthcare exposure is
common [13]. Furthermore, some reports suggest traditionally
CA-MRSA may be replacing traditionally HA-MRSA in hospitals
[15–18].
USA300 (t008/ST8) is the predominant, traditionally CA-
MRSA clone in the US that has rapidly disseminated and replaced
USA400 (ST1 and spa types t127, t128 and t1178) since its
isolation in 2000. Traditional CA-MRSA such as USA300 have
characteristics that may offer a selective advantage over HA-
MRSA, making it a strong competitor in the healthcare setting.
While the genetic backgrounds and epidemiology of MRSA are
rapidly evolving, in general CA-MRSA contain a smaller SCCmec
element (usually type IV) than HA-MRSA (usually SCCmec types
I-III), and also harbor fewer antibiotic resistance genes than
healthcare-associated strains, which may result in a fitness benefit,
and have a higher growth rate in vitro that may lead to successful
colonization by outcompeting HA-MRSA [19]. Furthermore, the
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linkage of the arginine catabolic mobile element with SCCmec type
IV in USA300 likely also confers increased fitness and/or
pathogenicity [20]. Finally, greater expression of regulatory genes
associated with the virulence factors panton-valentine leukocidin
(PVL) and alpha-toxin has been shown in USA300 versus USA400
isolates, which may contribute to the invasiveness of USA300 [21],
although there is evidence from neonatal units that CA-MRSA do
not need PVL to cause nosocomial infections [13,22–24].
In addition, as CA-MRSA strains move into the healthcare
setting and are exposed to nosocomial antibiotic pressure, they
have developed greater antibiotic resistance [25,26]. Even CA-
MRSA causing skin infections are becoming more resistant,
although such multiple resistance remains low in many US centers
[25,27–29]. In one US study, USA300 isolates classified as
healthcare-associated were significantly more likely to be cipro-
floxacin-resistant than USA300 isolates classified as community-
associated [30], and another study reported a USA300 isolate with
intermediate vancomycin susceptibility and reduced daptomycin
susceptibility from a hospital in San Francisco in 2007 [31]. As
traditionally CA-MRSA strains continue to encroach on health-
care MRSA reservoirs, they may come to resemble the antibiotic
resistance profiles of traditionally HA-MRSA and produce
healthcare-associated infections [13,32–34]. While it is not clear
if CA-MRSA cause more severe disease in the healthcare setting
and whether they are more transmissible than HA-MRSA, their
higher fitness and growth rate could lead to increasing prevalence
in hospitals [35].
Most prior studies of CA-MRSA penetration into hospital
reservoirs involve a single center, although nationally representa-
tive data have been presented recently [17,18]. Regional
evaluation of healthcare facilities may provide further information
about the extent of reservoir mixing of traditional CA-MRSA and
HA-MRSA strains across community and academic healthcare
facilities, as well as pediatric hospitals and long-term acute care
facilities. A prospective, population-based study of clinical MRSA
isolates across nine medical centers in San Francisco, California,
found that USA300 was the predominant clone in both the
community and hospital setting [36]. While this city-based study
collected almost 4000 MRSA isolates, only a fifth of these were
selected for molecular analysis, with the primary goal to determine
clonal groupings based upon the isolate collection date (hospital-
onset or community-onset). Further comprehensive evaluations of
the diversity of isolates within and across clonal complexes will
provide valuable information about how strains are evolving and
being shared across facilities. A better understanding of the
frequency and diversity of community- and healthcare-associated
MRSA clones may inform strategies to prevent MRSA trans-
mission and disease in the US.
We therefore conducted a prospective cohort study of inpatients
in a large metropolitan county, covering 30 medical facilities and
strain typing all MRSA isolates collected from both adult and
pediatric patients, to investigate the frequency and genetic
diversity of MRSA at a population level.
Materials and Methods
Study
We conducted the study as described previously [37]. This study
was approved by the Institutional Review Board of the University
of California Regents, and a waiver of informed consent was
granted.
Isolate Collection
Clinical (non-screening) isolates of MRSA from unique patients
were collected from hospital microbiology laboratories between
October 2008 and April 2010. Hospitals were instructed to collect
non-blood MRSA isolates from unique patients up to a total of 100
or for a duration of 12 months, whichever came first. In addition,
hospitals were instructed to collect all blood isolates from unique
patients for the same 12-month period as non-blood isolates.
Isolates from patients not admitted to hospital were excluded from
the study. Samples were processed as described previously [37].
Specimen Data and Hospital Characteristics
Specimen data, hospital characteristics and the Orange County
population estimate were obtained as described previously [37].
Laboratory Methods and Molecular Typing
All laboratory methods and molecular typing (spa typing, multi
locus sequence typing (MLST) and SmaI pulsed-field gel
electrophoresis (PFGE)) were performed as described previously
[37]. spa typing was performed on all collected isolates. MLST and
PFGE were performed on a subset of isolates (N= 284), selected as
described previously [37], to confirm strain types and assign
isolates to the major US MRSA clones (USA100, USA300 etc).
Definitions
Throughout this study the terms ‘‘traditionally CA-MRSA’’ and
‘‘traditionally HA-MRSA’’ were used to emphasize that, while
certain clones were originally identified as community- or
healthcare-associated, such clones may well be present and/or
established in both settings today. We used this terminology in
order to more clearly evaluate any mixing of MRSA reservoirs.
We also classified MRSA isolates according to the timing of
isolation with respect to patient admission date. Thus, community-
onset MRSA was defined as MRSA isolated less than three days
after admission, and hospital-onset MRSA as MRSA isolated three
or more days after admission.
Statistical Analyses
We calculated the number of hospitalized patients with MRSA
clinical cultures among both the total population of Orange
County and total annual admissions across all 30 hospitals,
accounting for duration of isolate collection within each hospital.
The number of community-onset and hospital-onset MRSA
clinical cultures among the total Orange County population was
also calculated. x2 tests were performed to compare the number of
isolates belonging to spa types t008 and t002/t242 between
Table 1. Summary of the 30 participating hospitals in Orange
County, CA.
Characteristic Median (IQRa)
Annual admissions 7868 (2819–16157)
% Hispanic patients 19.2 (11.4–32.9)
% Medicaid-insured patients 15.1 (5.8–34.6)
N MRSA isolates per hospital per month 4.7 (2.5–11)
N spa types per hospital 14 (7–17)
N LTAC-facilitiesb (No. isolates (%)) 6 (132 (5.9))
aIQR = interquartile range.
bLTAC = long-term acute care.
doi:10.1371/journal.pone.0062117.t001
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hospitals. One-sample z-tests for equality of proportions were
conducted, to compare the number of isolates belonging to spa
types t008 and t002/t242 within each hospital, as well as the
number of t002 and t242 isolates within each hospital. Simpson’s
index of diversity (12D) was used to estimate inter- and intra-
hospital genetic diversity of the MRSA strains collected, as well as
the genetic diversity of the two major spa-CCs. 12D gives an
unbiased measure of the probability of drawing two different spa
types given the distribution of spa types in a sample [38]. 95%
confidence intervals (CIs) were calculated as described previously
[39]. For comparison of diversity indices, a significant difference
(p,0.05) was determined by non-overlapping 95% CIs. Pearson’s
correlation coefficients were computed to determine the relation-
ship between hospital-level and isolate variables, and genetic
diversity. Due to the small sample size (28 hospitals; two were
excluded as they collected ,10 MRSA isolates and thus their
diversity estimates were unreliable) and the number of potential
predictor variables for genetic diversity, variables were considered
for entry into a bootstrapped multiple linear regression model
based on a combination of their correlation coefficient and current
knowledge regarding their association with MRSA. Only variables
with p,0.1 in correlation tests were considered for the exploratory
model. All statistical tests were performed using STATA (release
11, StataCorp 2009).
Results
Overview
Between October 2008 and April 2010, 2,246 clinical MRSA
isolates were collected from 30 Orange County hospitals. Annual
population incidence of clinical inpatient MRSA isolates in
Orange County was estimated at 86/100,000 people, with
inpatient risk estimated at 91/10,000 admissions. Annual popu-
lation incidence of clinical inpatient MRSA isolates in Orange
County that were community-onset was estimated at 60/100,000
people (62/10,000 admissions); incidence of those that were
hospital-onset was estimated at 25/100,000 people (26/10,000
admissions). Most clinical MRSA isolates were isolated from
wounds or abscesses (47%), in non-intensive care units (non-ICUs;
84%), and were community-onset (72%). Median patient age was
64 (IQR, 44–79; 13 missing values). Tables 1 and 2 give
a summary overview of the participating hospitals and isolate
characteristics.
Spa Typing and MLST
Among the 2,246 MRSA isolates collected, 134 spa types were
identified, including one non-typeable (NT) isolate and 28 spa
types (1.6% of all isolates) that did not match any known spa
sequence. These novel spa sequences were automatically submitted
to the Ridom SpaServer via the Ridom StaphType software and
were assigned new spa types. The isolate with the NT spa type was
re-tested to confirm the result was not due to a processing error,
and the sequence quality was deemed excellent by the StaphType
software. The NT spa type bore closest resemblance to t008, with
a missing nucleotide in the ninth repeat, making the repeat 23-bp
long. This is surprising since it would put the spa coding region out
of frame although others have reported spa repeats with an
unexpected length (J. Rothganger, Ridom GmbH, personal
communication). The NT spa type was submitted to Ridom for
their records. The three most common spa types were t008, t242
and t002, representing 83% of all isolates collected (Table 3). The
remaining 131 spa types represented 1.5% or less of all isolates
(Tables 3 and S1).
BURP analysis of the spa types clustered 96% of isolates into two
large spa-CCs and 1.2% of isolates into six smaller spa-CCs
(Figure 1). 78% of spa types were clustered into either spa-CC242
Table 2. Summary of the 2,246 clinical MRSA isolates from hospital inpatients in Orange County, CA.
Characteristica Total isolates, N t008 isolates, N (%) t242 isolates, N (%) t002 isolates, N (%)
Blood Specimens 213 81 (38) 47 (22.1) 30 (14.1)
Non-Blood Specimens 2,016 939 (46.6) 431 (21.4) 316 (15.7)
Wound/Abscess 1047 669 (63.9) 113 (10.8) 101 (9.7)
Sputum 596 159 (26.7) 186 (31.2) 146 (24.5)
Urine 189 33 (17.5) 87 (46) 38 (20.1)
Other 184 78 (42.4) 45 (24.5) 31 (16.9)
ICUb collection 374 121 (32.4) 100 (26.7) 85 (22.7)
Hospital-onset 627 239 (38.1) 160 (25.5) 122 (19.5)
a17 missing values for specimen source.
bICU= intensive care unit.
doi:10.1371/journal.pone.0062117.t002
Table 3. 10 most frequent spa types and their MLST types
among isolates from hospital inpatients in Orange County,
CAa.
Rank spa type MLST Freq % Cumulative %
1 t008 8 1034 46 46
2 t242 5 478 21.3 67.3
3 t002 5 347 15.4 82.8
4 t024 8 33 1.5 84.2
5 t037 8 25 1.1 85.4
6 t045 5 22 1.0 86.3
7 t088 105 21 0.9 87.3
8 t127 474b 18 0.8 88.1
9 t306 5 14 0.6 88.7
10 t1737 5 12 0.5 89.2
– Other – 242 10.8 100.0
aThe total number of spa types was 134, including one non-typeable isolate.
Simpson’s index of diversity (12D) value was 72% (95% CI 70%–73%).
MLST =multilocus sequence type.
bt127 isolates were also ST1 and ST1900, both SLVs of ST474.
doi:10.1371/journal.pone.0062117.t003
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(founder t242) or spa-CC008 (founder t008), including 18 and 8
novel spa types, respectively. Under the BURP algorithm, spa types
that differ from all other spa types in the sample by more than 4
repeats cannot reasonably be clustered into a spa-CC, and are
termed singletons. Nine spa types (56 isolates) were classed as
singletons, including two novel spa types. Six isolates represented
six spa types that were less than five repeats in length and were
excluded from BURP analysis because no reliable evolutionary
history can be inferred from ‘short’ spa types [40]. The NT isolate
could not be included in the BURP algorithm. Estimated genetic
diversity of MRSA in Orange County hospitals using spa typing
was high, at 72% (Table 3).
To confirm strain types, 284 isolates were selected for MLST.
Among the 23 unique sequence types (STs) identified, ST5 (45%),
ST8 (38%) and ST105 (4%) were the three most common, with
the vast majority of isolates (90%) belonging to one of two major
MLST CCs: CC5 (50%; four STs) and CC8 (40%; three STs)
(Table 4). According to MLST, t008 isolates were ST8 and t002
isolates were ST5. t242 isolates were also identified as ST5
(Tables 3 and 4). PFGE of the subset of isolates (N= 284)
confirmed that t008/ST8 isolates were the prototypic community
clone USA300 and t002/ST5 and t242/ST5 isolates were
predominantly the prototypic hospital clone USA100 (data not
shown). spa type t242 differs from t002 by one spa repeat, as a result
of a single nucleotide difference. The non-typeable spa isolate was
ST8, with 64% of the novel spa types being ST5 and 36% ST8.
Inter-hospital Differences
The estimated genetic diversity of MRSA within hospitals
ranged from 33% to 79% (Figure 2). Percentage of blood
specimens isolated per hospital and the median age of patients
that specimens were collected from were positively correlated with
genetic diversity within hospitals (r = 0.57, p,0.01 and r = 0.78,
p,0.001 respectively). Significant negative correlations were found
between genetic diversity of hospital MRSA isolates and the
percentage of Medicaid-insured patients (r =20.57, p,0.01),
Hispanic patients (r =20.38, p=0.04) and wound/abscess speci-
mens (r =20.65, p,0.001) per hospital. Percentage of Hispanic
patients and percentage of Medicaid-insured patients were highly
correlated (r = 0.85, p,0.001), and since both are markers for
patients from economically disadvantaged/high-density areas, the
former was not considered for entry into the bootstrapped linear
regression model. Only percentage of blood specimens and
median patient age remained significantly correlated to genetic
diversity in the exploratory regression model (coefficient = 0.82,
bootstrap standard error = 0.24, normal-based 95% CI= 0.35–
Figure 1. Relatedness of spa types among hospital MRSA isolates. Relatedness computed using the Based Upon Repeat Pattern (BURP)
algorithm. Clusters of linked spa types correspond to spa clonal complexes (spa-CC). spa types are clustered into a spa-CC when their repeat patterns
differ by no more than 4 repeats. BURP sums up ‘costs’ (a measure of relatedness based on the repeat pattern) to define a founder-score for each spa
type in a spa-CC. The founder (black node) is the spa type with the highest founder-score in its spa-CC, and the subfounder (dark gray node) is the spa
type with the second highest founder-score. spa-CC008 has founder t008, and spa-CCNF refers to a spa-CC with no founder. Each node represents
a spa type. Node size represents the number of clustered strains that belong to that spa type. The shading of the branches represents the ‘costs’
(similarities in repeat patterns) between two spa types; the darker the branch, the lower the cost (more similar repeat patterns).
doi:10.1371/journal.pone.0062117.g001
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1.29, p,0.01 and coefficient = 0.44, bootstrap standard er-
ror = 0.08, normal-based 95% CI= 0.28–0.60, p,0.001 respec-
tively).
The three most common spa types – t008, t242 and t002 -
accounted for 65–95% of isolates at each hospital, showing that
these spa types are consistently dominant across Orange County
hospitals (Table S1). The proportion of t008 (USA300) isolates
compared to t002/t242 (USA100) isolates varied significantly
between hospitals (x2 = 233.22, df = 29, p,0.001) (Figure 2). Four
hospitals (13.3%) had significantly more t002/t242 (USA100)
isolates, whereas 15 hospitals (50%) had significantly more t008
(USA300) isolates (p,0.05). Of the t002/t242 isolates, 12 (40%)
hospitals had significantly more t242 isolates, whereas five
hospitals (16.7%) had significantly more t002 isolates (p,0.05).
One hospital isolated no t002/t242 isolates. The four hospitals
with significantly more t002/t242 (USA100) isolates than t008
(USA300) isolates were medium to large non-teaching acute care
hospitals. Diversity of spa types among spa-CC008 (12D=22%
(95% CI, 19–26%)) was significantly lower than diversity among
spa-CC242 (12D=63% (95% CI, 61–66%)).
Discussion
We conducted a prospective cohort study of inpatients in a large
metropolitan county, collecting all clinical MRSA isolates from 30
of 31 hospitals in order to investigate the frequency and genetic
diversity of MRSA at a population level, and provide further
information about the extent of community and healthcare MRSA
reservoir mixing. To our knowledge, this is the first study to assess
MRSA isolates from a population-based sample across a large
region. While Liu et al. conducted a large population-based study
of clinical MRSA isolates in both hospital inpatients and
outpatients, they sampled from a single city and characterized
only 20% of all MRSA isolates collected [36]. Our countywide
study was more comprehensive, encompassing 30 hospitals and
characterizing all inpatient clinical MRSA isolates (over 2000).
Countywide, three spa types dominated clinical MRSA isolates.
USA300 (t008/ST8), the traditionally community-associated clone
prevalent in the US, was the most common clone, making up just
under half of all clinical MRSA isolates. USA100 (t002/ST5), the
traditionally healthcare-associated clone, was also common, but
interestingly, t242/ST5 isolates were slightly more common than
t002/ST5 isolates. Given the clinical similarities of t242 and t002
isolates found in our previous study [37], and that PFGE showed
a sample of t242 and t002 isolates to be predominantly USA100,
t242/ST5 likely represents a variant of USA100 that has become
prevalent in Orange County hospitals [37]. t242 has been reported
sporadically elsewhere, but was endemic in one hospital in Italy
[41–44]. USA300 was the predominant clone in San Francisco
hospitals in 2004–2005, followed by strains of the CC5 lineage
[36].
Most spa types were closely related to either the USA300 or
USA100 clone, creating two distinct spa-CCs. The remaining
unrelated spa types were clustered into six small spa-CCs
representing several traditionally community- and healthcare-
associated clones, but occurred only sporadically. The largest of
these spa-CCs represented ST72, an invasive community-associ-
ated clone that was reported in elderly patients in South Korea just
before our isolate collection began [45]. According to the US 2010
Census (factfinder2.census.gov), 17.9% of the Orange County
population is Asian of which approximately 2.9% are Korean.
ST72 strains belong to CC8 and have also been reported in
Australia and Europe [46]. The other spa-CCs represented clones
including the traditionally community-associated ST59 (WA-
MRSA 15, t976) and ST30 (USA1100/Southwest Pacific clone),
plus the ST97 clone reported only once before in the US [46,47].
MSSA from the CC97 lineage are often isolated from cattle but
only occasionally from humans, and MRSA from this lineage are
rare [46].
The remaining two small spa-CCs included the traditionally
hospital-associated clones USA600 (ST45/Berlin clone) and
EMRSA-15 (ST22), however the latter has recently been reported
in the community setting [48]. Among the few isolates not
belonging to a spa-CC was the traditionally HA-MRSA clone
USA200 (ST36/EMRSA-16), isolates representing the pandemic
ST239 clone and isolates representing strains of MLST CC1,
a traditionally CA-MRSA lineage that includes USA400. Most
isolates of this latter group were spa type t127 and ST474, a SLV
of ST1. ST1/t127 is one of the most common CA-MRSA strains
in the UK [49]. t127 was also recently reported among US isolates
by Tenover et al [18]. While there is MRSA diversity in the
Orange County population, USA300 and USA100 continue to
dominate in hospitals, with most diversity caused by their close spa-
type relatives.
Table 4. Relatedness of MLST types of 284 hospital MRSA
isolates according to eBURSTa.
CC (no. of isolates)b MLST Associated spa typesc
CC5 (142) 5 t242, t002, t045
105 t088, t045
225 t045
840 t088
CC8 (114) 8 t008, t024, t037
239 t037
576 t1635
CC474 (9) 474 t127
1900 t127
1 t127
CCNF1 (4) 45 t004, t026, t040
1811 t1081
CCNF2 (3) 59 t3424, t976
87 t216
CCNF3 (2) 36 t018
30 t019
Singletons (10)d 72 t126, t148, t324
22 t005
12 t160
88 t5916
97 t359
188 t189
635 t044
aMLST =multi-locus sequence typing; eBURST = Based Upon Related Sequence
Types algorithm.
bCC= clonal complex. All members of a CC share identical alleles at six of the
seven loci with at least one other member of the CC. CCNF refers to a CC with
no predicted founder genotype.
cOnly the three most common spa types are listed if more than three associated
with that sequence type (ST).
dSTs with allelic profiles that share less than six of their seven loci with all other
STs in the dataset.
doi:10.1371/journal.pone.0062117.t004
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Overall genetic diversity of MRSA in Orange County was
relatively high, but heterogeneous between hospitals. This
variation in diversity was mostly non-significant, with all hospitals
dominated by the three most common spa types t008, t242 and
t002. Diversity was significantly lower among spa-CC008 isolates
than spa-CC242 isolates. Since the founder of spa-CC008 is the
traditionally community-associated USA300, perhaps this clonal
complex represents younger strains that have had less time to
diversify compared to those in spa-CC242, which is largely
represented by the traditionally healthcare-associated clone
USA100. In an exploratory model, genetic diversity was signifi-
cantly associated with older patient age and isolation of MRSA
from blood specimens. Clones traditionally associated with the
healthcare setting are typically isolated from older patients,
whereas clones traditionally linked to the community setting,
which have had less time to diversify, are associated with children
and young adults [37]. Blood infections are commonly associated
with the use of invasive medical devices such as indwelling
catheters and are historically caused by healthcare-associated
strains, which are more established and thus more diverse. This
picture is rapidly changing however, with recent studies by
O’Hara et al and Tenover et al demonstrating the increasing
prevalence and dominance of USA300 isolates among invasive
isolates [17,18].
The vast majority of MRSA isolates were obtained within the
first two days of hospitalization, suggesting that MRSA hospital
reservoirs are mainly maintained by importation. Such commu-
nity-onset isolates can include healthcare-associated carriage or
infection isolates which are often found on readmission to hospitals
[50,51]. A history of healthcare exposure however does not
exclude the possibility of MRSA acquisition and onset in the
community [50].
The high penetration of USA300 into Orange County hospitals
highlights the potential need for community-based strategies to be
implemented in an effort to address the MRSA epidemic in the
community and minimize the ability of traditional community-
associated MRSA strains to become endemic in all hospitals.
Whether all hospitals will eventually become dominated by
traditional community-associated MRSA strains remains to be
seen. t008 (USA300) is currently the most frequent strain in 80%
of Orange County hospitals. The consequences of CA-MRSA
continuing to infiltrate the healthcare setting include 1) the
emergence of multidrug resistant CA-MRSA due to nosocomial
antibiotic pressure [52], 2) the potential of increased virulence of
healthcare-associated infections due to PVL-positive CA-MRSA
strains, although studies suggest CA-MRSA are clinically similar to
HA-MRSA once in the healthcare setting [34], and 3) the risk of
hospital outbreaks due to the influx of CA-MRSA from the ever-
expanding community reservoir [35,52,53].
A limitation of this study was that few individual level
characteristics were available. Also, we could not account for
variation among hospitals in obtaining clinical cultures. We
excluded screening cultures since mandatory screening of high-risk
inpatients was not in place in California until 2009 and capture
would have been inconsistent across facilities. Therefore, our
population estimate of MRSA isolates from hospital inpatients is
likely an underestimate. In addition, our estimate should not be
construed as a measure of MRSA infection among inpatients.
Clinical isolates often represent carriage without infection. Due to
the study design, we were unable to distinguish between infection
Figure 2. Relative proportion of isolates with spa type t008 versus spa types t002/242, by hospital. *indicates a significant difference at
the 95% level in the relative proportion of isolates with spa type t008 and spa types t002/242 at that hospital. The black bars show the point
estimates and 95% confidence intervals of hospital-specific genetic diversity expressed as Simpson’s index of diversity (12D) of spa types (as
a percentage). Diversity indices for hospitals 11 and 13 were excluded from the figure as these hospitals had spa type data for less than ten isolates (4
and 6 isolates in total, respectively. Diversity indices with non-overlapping 95% CIs were considered significantly different (p,0.05). The hospital-
specific proportions of t008 among all spa types have been previously reported [59].
doi:10.1371/journal.pone.0062117.g002
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and colonization isolates. Finally, our estimates of the indices of spa
type diversity within hospitals may have been influenced by
differing sample sizes [39].
PFGE is the gold standard for MRSA typing and is one of the
most discriminatory typing methods for studying local MRSA
epidemiology such as outbreaks and nosocomial transmission
[54,55]. Unfortunately, PFGE is laborious and time-consuming,
making it unsuitable for high-throughput typing of large numbers
of isolates. The sequence-based methods of MLST and spa typing
were used in this study because they are simpler and quicker to
perform and unambiguous. Because of the need to sequence seven
loci, MLST is less efficient than spa typing for a large number of
isolates as in this study. Consequently, MLST was only performed
on a subset of the isolates. This was also true for PFGE. spa typing
is a single-locus method, and its discriminatory power lies between
that of PFGE and MLST, making it suitable for studying hospital
outbreaks and transmission as well as clonal evolution [56,57].
These reasons made spa typing the method of choice for
chracterising the 2,246 MRSA isolates in this study. A recent
study found that spa type t008 has high specifity and sensitivity
with regards to identifying USA300 isolates (95 and 93%
respectively) [58]. Furthermore, spa type t008 in combination
with MLST ST8 was shown to be highly specific (98%), meaning
that this combination of genetic markers rarely identified a non-
USA300 isolate [58]. Reducing the cost of whole genome
sequencing will in future provide the ultimate tool for the
molecular epidemiology of MRSA [58].
This study was designed to assess the extent of MRSA reservoir
mixing and to examine how this varies across hospitals within
a single, large US county. When combining data from all hospitals,
we found that t008 (USA300) and t002/t242 (USA100) isolates
dominated the hospital setting, with t008 (USA300) as the single
most prevalent clone. Nevertheless, when evaluating individual
hospitals, we found that genetic diversity was high and substantial
variation existed. Genetic diversity of MRSA appeared to be
driven by spa types closely related to those of t002 and t242
(USA100). The USA100 variant t242/ST5 was more prevalent
than t002/ST5 and found in most Orange County hospitals.
USA300 was originally recognized as a community-associated
MRSA strain but is now well established alongside traditional
healthcare-associated MRSA strains in many hospitals, including
those in Orange County, making the distinction between
community-associated and hospital-associated strains increasingly
untenable. Nevertheless, in 20% of hospitals, USA300 was not yet
the dominant strain, suggesting that community-based MRSA
control strategies may still be helpful in stemming the influx of
traditionally community-associated strains into healthcare settings.
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